Thrombocytopenia
MONDO:0002049A laboratory test result indicating that there is an abnormally small number of platelets in the circulating blood.
Also known as: platelet count decreased, thrombocytopenic disorder
266 clinical trials for this condition and its sub-types, 74 tagged with Thrombocytopenia itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Thrombocytopenia
-
Thrombocytopenic purpura 8 trials · 116 incl. sub-types
2 sub-types
- Autoimmune thrombocytopenic purpura 95 trials
- Thrombotic thrombocytopenic purpura 15 trials · 20 incl. sub-types Sub-types →
-
Autoimmune thrombocytopenia 8 trials · 113 incl. sub-types
2 sub-types
- Autoimmune thrombocytopenic purpura 95 trials
- Evans syndrome 19 trials
-
Inherited thrombocytopenia 2 trials · 29 incl. sub-types
21 sub-types
- Thrombocytopenia 1 9 trials
- Syndromic constitutional thrombocytopenia 0 trials · 8 incl. sub-types Sub-types →
- Congenital amegakaryocytic thrombocytopenia 4 trials · 6 incl. sub-types Sub-types →
- Congenital thrombotic thrombocytopenic purpura 5 trials
- Alpha granule disease 0 trials Sub-types →
- Autosomal dominant macrothrombocytopenia 0 trials Sub-types →
- Congenital autosomal recessive small-platelet thrombocytopenia 0 trials
- Isolated delta-storage pool disease 0 trials
- Macrothrombocytopenia, isolated 0 trials Sub-types →
- Thrombocytopenia 10 0 trials
- Thrombocytopenia 11 with multiple congenital anomalies and dysmorphic facies 0 trials
- Thrombocytopenia 12 with or without myopathy 0 trials
- Thrombocytopenia 13, syndromic 0 trials
- Thrombocytopenia 2 0 trials
- Thrombocytopenia 3 0 trials
- Thrombocytopenia 4 0 trials
- Thrombocytopenia 5 0 trials
- Thrombocytopenia 7 0 trials
- Thrombocytopenia 9 0 trials
- Thrombocytopenia, X-linked, with or without dyserythropoietic anemia 0 trials Sub-types →
- Thrombocytopenia, cyclic 0 trials
-
Acquired thrombocytopenia 11 trials · 24 incl. sub-types
1 sub-type
-
Neonatal thrombocytopenia 5 trials
1 sub-type
- Transient neonatal thrombocytopenia 0 trials
Most studied deeper sub-types
-
Tailored drug regimen shows promise for rare blood disorder
Disease control Stopped earlyThis study tested whether giving the drug caplacizumab based on regular blood tests (ADAMTS13 activity) could improve outcomes for adults with acquired thrombotic thrombocytopenic purpura (aTTP), a rare condition causing dangerous blood clots. The trial enrolled 58 adults and mon…
Phase 2 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Bleeding breakthrough fizzles: fibrinogen trial for chemo patients halted after just one patient
Disease control Stopped earlyThis study tested a single injection of fibrinogen concentrate followed by a platelet transfusion in blood cancer patients with severe bleeding who did not respond to standard platelet transfusions. The goal was to see if it improved blood clotting. However, the trial was termina…
Phase 2 • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Promising drug for Post-Transplant blood issues falls short in early trial
Disease control Stopped earlyThis study tested a drug called fostamatinib to help people whose blood cell counts drop after a stem cell transplant. The goal was to see if the drug could raise red blood cells or platelets without needing transfusions. The trial was stopped early after enrolling only one perso…
Phase 2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Experimental drug aims to restore platelets in Heparin-Triggered disorder
Disease control Stopped earlyThis study tested an experimental drug called VLX-1005 in people with a rare condition where the blood thinner heparin causes a dangerous drop in platelets (cells that help blood clot). Participants received either VLX-1005 or a placebo alongside standard care. The goal was to se…
Phase 2 • Sponsor: Veralox Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Experimental drug iptacopan tested for rare blood disorders
Disease control Stopped earlyThis study tested an experimental drug called iptacopan in people with two rare blood disorders: immune thrombocytopenia (ITP) and cold agglutinin disease (CAD). The goal was to see if the drug could improve platelet counts in ITP or hemoglobin levels in CAD. The trial was termin…
Phase 2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Promising FNAIT prevention study halted early after just one participant
Prevention Stopped earlyThis study tested a drug called RLYB212 in pregnant women at high risk for a condition where the mother's immune system attacks the baby's platelets, causing dangerous bleeding. The goal was to see if the drug was safe and how it moved through the body. Only one woman enrolled be…
Phase 2 • Sponsor: Rallybio • Aim: Prevention
Last updated Jun 27, 2026 09:11 UTC